MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $9,054,000 | +31.9% | 196,917 | +38.7% | 0.57% | -39.7% |
| Q4 2015 | $6,865,000 | +68.1% | 142,017 | +47.8% | 0.94% | +934.1% |
| Q3 2015 | $4,084,000 | +186.0% | 96,101 | +668.8% | 0.09% | +145.9% |
| Q2 2015 | $1,428,000 | -74.1% | 12,500 | -70.8% | 0.04% | -73.0% |
| Q1 2015 | $5,524,000 | +490.2% | 42,802 | +355.3% | 0.14% | +47.3% |
| Q4 2014 | $936,000 | -91.9% | 9,400 | -92.0% | 0.09% | -69.3% |
| Q3 2014 | $11,606,000 | – | 117,389 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |